A post-radical-prostatectomy nomogram incorporating new pathological variables and interaction terms for improved prognosis

BJU International

Volumn 107, Issue 3, 2011, Pages 389-395

  O'Brien, Beverley A ^a   Cohen, Ronald J ^a   Wheeler, Thomas M ^b   Moorin, Rachael E ^c  

^a Tissugen Pty Ltd   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

nomograms; prognosis; proportional hazards models; prostate; prostatic neoplasms

Indexed keywords

ADULT; AGED; ARTICLE; CALIBRATION; CANCER RECURRENCE; COHORT ANALYSIS; DISCRIMINANT ANALYSIS; HUMAN; INTRADUCTAL CARCINOMA OF THE PROSTATE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS; NOMOGRAM; ORGAN WEIGHT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; PROSTATE TUMOR; PROSTATECTOMY; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; EPIDEMIOLOGIC METHODS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NOMOGRAMS; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS;

EID: 79251574663     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09539.x     Document Type: Article

References (26)

1. Kattan MW,. Do we need more nomograms for predicting outcomes in patients with prostate cancer? Nat Clin Pract Urol 2008; 5: 366-7
2. Touijer K, Scardino PT,. Nomograms for staging, prognosis and predicting treatment outcomes. Cancer 2009; 115 (13 Suppl.): 3107-11
3. Kattan MW, Wheeler TM, Scardino PT,. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol 1999; 17: 1499-507
4. Stephenson AJ, Scardino PT, Easthan JA, et al. Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 2005; 23: 7005-12
5. Kattan MW, Vickers AJ, Changhong Y, et al. Preoperative and postoperative nomograms incorporating surgeon experience for clinically localized prostate cancer. Cancer 2009; 115: 1005-10
6. Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM,. Biological determinants of cancer progression in men with prostate cancer. JAMA 1999; 281: 1395-400
7. Cheng L, Koch MO, Juliar BE, et al. The combined percentage of Gleason patterns 4 and 5 is the best predictor of cancer progression after radical prostatectomy. J Clin Oncol 2005; 23: 2911-7
8. Vis AN, Roemeling S, Kranse R, Schröder FH, van der Kwast TH,. Should we replace the Gleason score with the amount of high grade prostate cancer? Eur Urol 2007; 51: 931-9
9. Norris AM, Gentry M, Peehl DM, D'Agostino R Jr, Scarpinato KD,. The elevated expression of a mismatch repair protein is a predictor for biochemical recurrence after radical prostatectomy. Cancer Epidemiol Biomarkers Prev 2009; 18: 57-64
10. Freedland SJ, Isaacs WB, Platz EA, et al. Prostate size and risk of high-grade, advanced prostate cancer and biochemical progression after radical prostatectomy: A Search database study. J Clin Oncol 2005; 23: 7546-54
11. Cohen RJ, Chan WC, Edgar SG, et al. Prediction of pathological stage and clinical outcome in prostate cancer: An improved pre-operative model incorporating biopsy-determined intraductal carcinoma. Br J Urol 1998; 81: 413-8
12. Iasonos A, Schrag D, Raj GV, Panageas KS,. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol 2008; 26: 1364-70
13. Harrell FE, Lee KL, Mark DB,. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-87
14. Briganti A, Blute ML, Eastham JH, et al. Pelvic lymph node dissection in prostate cancer. Eur Urol 2009; 55: 1251-65
15. Graefen M, Karakiewicz PI, Cagianos I, et al. Validation study of the accuracy of a postoperative nomogram for recurrence after radical prostatectomy for localized prostate cancer. J Clin Oncol 2002; 20: 951-6 (Pubitemid 34141837)
16. Thanigasalam R, Rasiah KK, Stricker PD, et al. Stage migration in localized prostate cancer has no effect on the post-radical prostatectomy Kattan nomogram. BJU Int 2010; 105: 642-7
17. Cook NR,. Statistical evaluation of prognostic versus diagnostic models: Beyond the ROC curve. Clin Chem 2008; 54: 17-23
18. Stephenson AJ, Kattan MW, Eastham JA, et al. Defining biochemical recurrence of prostate cancer after radical prostatectomy: A proposal for a standardized definition. J Clin Oncol 2006; 24: 3973-8
19. Gallina A, Chun FK-H SN, et al. Comparison of stage migration patterns between Europe and the USA: An analysis of 11 350 men treated with radical prostatectomy for prostate cancer. BJU Int 2008; 101: 1513-8
20. Cohen RJ, Wheeler TM, Bonkhoff H, Rubin MA,. A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma. Arch Pathol Lab Med 2007; 131: 1103-9
21. Chun FK-H, Briganti A, Jeldres C, et al. Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy. Eur Urol 2007; 51: 949-55
22. Cohen RJ, Shannon BA, Phillips M, Moorin RE, Wheeler TM, Garrett KL,. Central zone carcinoma of the prostate gland: A distinct tumour type with poor prognostic features. J Urol 2008; 179: 1762-7
23. Nelson BA, Shappell SB, Chang SS, et al. Tumour volume is an independent predictor of prostate-specific antigen recurrence in patients undergoing radical prostatectomy for clinically localized prostate cancer. BJU Int 2006; 97: 1169-72
24. Wolters T, Roobol MJ, van Leeuwen PJ, et al. Should pathologists routinely report prostate tumour volume? The prognostic value of tumour volume in prostate cancer. Eur Urol 2010; 57: 821-9; doi:10.1016/j.eururo.2009.07.027
25. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC,. Natural history of progression after PSA elevation following radical prostatectomy. JAMA 1999; 281: 1591-7
26. Walz J, Chun FK-H, Klein EA, et al. Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer. J Urol 2009; 181: 601-8